CNTN2 and breast cancer: These findings on Tax activity in BRCA1-defective breast cancer cells are consistent with other studies that have reported interference of BRCA1 expression with the antitumour effects induced by antimicrotubule agents in cells derived from sporadic breast tumours (Lafarge et al, 2001; Mullan et al, 2001).